Gilead Sciences | GILD - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
AbbVie USD 508.97B 46.71B 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
ALKERMES USD 7.43B 629M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.09T 40.33B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Glaxosmithkline GBP 101.7B 4.58B 2026-11
Incyte USD 24.6B 1.95B 2026-09
J&J USD 653.61B 42.25B 2026-09
Merck USD 375.59B 17.09B 2026-11
Moderna USD 99.14B 22.26B 2026-11
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Pfizer USD 165.12B 1.71B 2026-11
Sanofi EUR 100.56B 13.53B 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
United Therapeutics USD 28.64B 5.4B 2026-11
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11